Viemed Healthcare, Inc. (NASDAQ:VMD) Q4 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Viemed Healthcare, Inc. Year End 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Viemed Healthcare Inc. (VMD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Kent Lake Capital Benjamin Natter | 1,300,000 | $10,426,000 | 4.4% | |
| 2. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 935,122 | $7,499,678 | -18% | 0.32% |
| 3. | Divisadero Street Capital William Zolezzi | 646,273 | $5,183,109 | +85% | 0.6% |
| 4. | Renaissance Technologies Jim Simons | 373,000 | $2,991,460 | +3% | 0% |
| 5. | First Eagle Investment Management Jean-Marie Eveillard | 328,824 | $2,637,168 | +197% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.10 | 2,000 | Director | 41,040 | 2024-05-14 | Filing | |
| $7.07 | 485 | Director | 39,040 | 2024-05-14 | Filing | |
| $7.01 | 335 | Director | 38,555 | 2024-05-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.73 | 3,000 | Director | 79,786 | 2025-03-14 | Filing | |
| $7.75 | 665 | Director | 82,786 | 2025-03-13 | Filing | |
| $7.65 | 2,000 | Director | 83,451 | 2025-03-13 | Filing | |
| $7.69 | 2,000 | Director | 85,451 | 2025-03-13 | Filing | |
| $7.70 | 4,200 | Director | 87,451 | 2025-03-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,088,818 | $24,772,321 | 0% | |
| 2. | 1,792,235 | $14,373,724 | 0% | |
| 3. | 1,717,498 | $13,774,334 | 5.76% | |
| 4. | 1,327,688 | $10,648,058 | 0.05% | |
| 5. | 845,651 | $6,782,121 | 0.37% |
News See All
Viemed Healthcare, Inc. (VMD): A Bull Case Theory
We came across a bullish thesis on Viemed Healthcare, Inc. (VMD) on Substack by Petty Cash. In this article, we will summarize the bulls’ thesis on VMD. Viemed Healthcare, Inc.
Viemed Healthcare, Inc. (NASDAQ:VMD) Q3 2024 Earnings Call Transcript
Operator: Greetings, and welcome to Viemed's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Viemed Healthcare, Inc. (NASDAQ:VMD) Q2 2024 Earnings Call Transcript
Operator: Good day ladies and gentlemen and welcome to the Viemed Second Quarter 2024 Earnings Call. Our host for today's call is Todd Zehnder, Chief Operating Officer.
Viemed Healthcare, Inc. (NASDAQ:VMD) Q1 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Viemed First Quarter 2024 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
Viemed Healthcare, Inc. (NASDAQ:VMD) Q4 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Viemed Fourth Quarter 2023 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
Should You Hold Viemed Healthcare (VMD)?
Wasatch Global Investors, an investment management firm, released its “Wasatch Micro Cap Value Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here.
Viemed Healthcare, Inc. (NASDAQ:VMD) Q3 2023 Earnings Call Transcript
Operator: Greetings, and welcome to Viemed's 3Q 2023 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
Should You Hold Viemed Healthcare (VMD) for the Long-Term?
Investment management company Cove Street Capital recently released its “Small Cap Value Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
Viemed Healthcare, Inc. (NASDAQ:VMD) Q2 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Viemed Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
